Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo, you cannot split a Wegovy dose. Each pre-filled Wegovy pen is a single-dose device: it delivers one precise, factory-set injection and cannot be divided, halved, or reused for a smaller amount. The dose you inject is the dose your prescriber has authorised for that week — altering it yourself would change your treatment without clinical oversight. Wegovy is a prescription-only medicine, and any adjustment to the schedule requires a prescriber to decide whether that change is appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question of splitting a Wegovy dose usually comes from a reasonable place: nausea on a higher strength, a missed delivery, or simply wanting more control over how the medicine enters your body. That instinct is understandable. But the pen itself closes off the option.
Wegovy is supplied as a pre-filled, single-use auto-injector. When you press the pen against your skin and activate it, it releases the entire pre-set dose in one movement. There is no dial, no partial-injection feature, and no reservoir you can draw from with a separate syringe. Once activated, the needle retracts and the pen locks permanently, by design, to prevent reuse and contamination. You can read how the pen works in detail on our Wegovy treatment overview.
The 7.2 mg pen approved by the MHRA on 14 April 2026 (a dedicated single weekly injection for adults with obesity) takes this further: it uses an auto-dosing mechanism with a built-in covered needle that locks after firing. Splitting a dose from this device is physically not possible.
So the first step is recognising that the pen is not just a container. It is a calibrated delivery system, and the full dose is what it is built to give.
The reason many people ask about splitting a semaglutide dose is that side effects, particularly nausea and stomach discomfort, tend to peak after starting treatment or moving up a strength. The licensed Wegovy schedule (starting at 0.25 mg and stepping through 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with roughly four weeks at each level) is specifically designed to manage that pattern. As the NHS guidance on semaglutide notes, side effects are generally most noticeable at the start of treatment or after a dose increase, and they usually settle within the first one to two weeks at a new strength.
Splitting the dose (injecting half a pen's contents, say) does not replicate a lower approved strength. The pharmacokinetics of weekly semaglutide are built around one injection, and a smaller unofficial amount would not correspond to any dose whose safety and effectiveness has been assessed. It could also disrupt the smooth build-up that the titration ladder is engineered to produce.
If side effects at a given step feel unmanageable, the right move is a conversation with your prescriber, not an improvised adjustment at home. A prescriber can delay a step, revisit the current dose, or review whether the schedule suits your particular response.
A prescriber cannot split a pen for you, but they have other tools. They can keep you at a lower strength for longer if tolerability is the concern, giving your body more time to adapt before the next step up. They can also assess whether a lower maintenance dose makes clinical sense for you, research suggests meaningful weight loss is achievable below the 2.4 mg maximum for some people, though the licensed schedule targets 2.4 mg as the maintenance dose.
Spending a quick minute before your next injection to note the time and any symptoms since the previous dose is a useful habit: if nausea tends to peak on day two, that pattern is exactly the kind of detail that helps a prescriber make a practical call. A short note on your phone is enough.
What a prescriber cannot do is sanction splitting or halving a dose as a routine strategy, because the pen design makes it impractical and the licensed dosing form does not support it. For more on how the full Wegovy dose schedule is structured, our guide to Wegovy doses sets out each step and what to expect.
A separate question worth distinguishing is whether a semaglutide dose could be taken twice a week at a lower frequency, that is a different kind of schedule change, and one our page on splitting semaglutide across two weekly injections addresses directly. It is also not how the medicine is licensed, but the mechanics and evidence behind that question are explored there.
If you are looking at Wegovy pricing and wondering whether taking less of a pen might make the medicine go further economically, it is worth reading our Wegovy price comparison page, which sets out what private prescriptions typically cost and what reputable providers include. Dose-stretching is not a safe route to savings with a prescription medicine.
Equally, if you have seen products labelled as compounded or unlicensed semaglutide (including some listed online with dose-splitting as a feature) the MHRA has repeatedly warned that semaglutide sold outside the licensed UK supply chain carries serious risks, and our page on Hemi Pharma semaglutide 5mg explains what that particular product is and how it sits within the regulatory landscape. Counterfeit and unregulated versions have been seized in large numbers across the UK. Pages offering prescription medicines without a valid prescription are a red flag worth reporting to the MHRA's Yellow Card scheme.
The short answer to this page's question remains: Wegovy pens are not designed to be split, and the licensed schedule does not include partial-dose options. If you want to explore whether Wegovy is right for you and have your dose plan set by a qualified clinician, start your free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.